Could a simple pill keep relapsed testicular cancer at bay?
NCT ID NCT04804007
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is for people with relapsed germ cell tumors (a type of cancer often in the testicles or ovaries) who have already had high-dose chemotherapy and a stem cell transplant. It tests whether taking a daily oral chemotherapy drug called etoposide for a while after treatment can help keep the cancer from coming back, compared to just watching and waiting. The trial will enroll 64 adults and track cancer progression and side effects over 12 months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GERM CELL TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Indiana University Melvin & Bren Simon Cancer Center
RECRUITINGIndianapolis, Indiana, 46202, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- High-Dose chemo with stem cell transplant tested against standard therapy for tough germ cell cancers
- Could a dementia drug shield kids' brains from radiation damage?
- Dietary change explored as cancer support strategy
- Hypnosis may ease chemo anxiety in teens and young adults
- Massive ovarian cancer screening trial tests whether early detection cuts deaths
- Experimental drug cocktail aims to outsmart childhood cancers